Michael Lane - Aug 3, 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Role
Executive Vice President
Signature
/s/ Lily J. Lu, Attorney-in-Fact for Michael Lane
Stock symbol
IDXX
Transactions as of
Aug 3, 2023
Transactions value $
-$5,169,173
Form type
4
Date filed
8/7/2023, 05:04 PM
Previous filing
May 8, 2023
Next filing
Nov 8, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IDXX Common Stock Options Exercise $214K +1.51K +37.48% $141.60 5.55K Aug 3, 2023 Direct F1
transaction IDXX Common Stock Options Exercise $1.33M +7.44K +134.06% $178.26 13K Aug 3, 2023 Direct
transaction IDXX Common Stock Options Exercise $1.47M +7.08K +54.54% $206.94 20.1K Aug 3, 2023 Direct
transaction IDXX Common Stock Sale -$8.17M -16K -79.89% $510.00 4.03K Aug 3, 2023 Direct F2
holding IDXX Common Stock 592 Aug 3, 2023 by spouse F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise $0 -1.51K -100% $0.00* 0 Aug 3, 2023 Common Stock 1.51K $141.60 Direct F4
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise $0 -7.44K -100% $0.00* 0 Aug 3, 2023 Common Stock 7.44K $178.26 Direct F5
transaction IDXX Incentive Stock Option (right-to-buy) Options Exercise $0 -7.08K -84.63% $0.00 1.29K Aug 3, 2023 Common Stock 7.08K $206.94 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
F2 Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
F3 Held by spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
F4 Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
F5 Grant of option to buy 9,434 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019.
F6 Grant of option to buy 8,366 shares of Issuer common stock that vested in five annual installments beginning February 14, 2020.